Stephanie Amiel is Emeritus Professor of Diabetes Research at King’s College London and honorary consultant to King’s College Hospital NHS Foundation Trust. She trained in medicine at Guy’s Hospital, London with Harry Keen and started her research career at Yale University, USA with Bob Sherwin and Bill Tamborlane. She is an experimental medicine researcher focussing particularly on the pathogenesis and prevention of hypoglycaemia in diabetes, with physiological studies and neuroimaging, development of the UK’s DAFNE structured education programme, deployment of new technologies for insulin administration and clinical islet transplantation, with current work addressing cognitive barriers to hypoglycaemia avoidance. In King’s clinical diabetes services, she led development of the type 1 diabetes service, islet transplantation and, with obstetric colleagues, improving outcomes of pregnancy. She is author of over 200 research papers, book chapters on diabetes management and reviews. She edited Diabetic Medicine and Diabetes Voice and worked on national and international consensus documents and guidelines including chairing the UK’s 2015 NICE guideline development committee for the diagnosis and treatment of type 1 diabetes in adults. She is CI for the HARPdoc trial funded by JDRF, and a co-investigator on the EU-IMI HypoRESOLVE project and on NIH’s impaired awareness of hypoglycaemia project.